Major parties committed to major medicines policy reform and reviews – whoever wins on Saturday

19 May 2022 - Medicines Australia has been assured in official communications from the respective Campaign Headquarters that both the ...

Read more →

High-risk COVID-19 patients can now get two antiviral prescription drugs — but some are still missing out

10 May 2022 - For Australians at high risk of developing severe COVID-19, getting access to potentially lifesaving treatment recently ...

Read more →

COVID-19 oral treatment listed on PBS from 1 May 2022

1 May 2022 - This prescription only oral treatment has been found to be effective in treating mild to moderate ...

Read more →

Schedule of Pharmaceutical Benefits - 1 May 2022

1 May 2022 - The May 2022 issue of the Schedule of Pharmaceutical Benefits is out and now in effect. ...

Read more →

New Pharmaceutical Benefits Scheme listings to save patients millions

1 May 2022 - Health Minister Greg Hunt has announced a series of new Pharmaceutical Benefits Scheme listings which will save ...

Read more →

PBS brings hope to cancer patients

25 April 2022 - Late-stage breast cancer patients, many of them young women, will have access to a life-extending medication ...

Read more →

Making #MedicinesMatter for all Australians

21 April 2022 - Medicines Australia has launched a social media campaign to highlight key policy issues for the election ...

Read more →

Securing the future of Australia’s world class healthcare system

17 April 2022 - Under the changes announced today, an additional 71,000 Australians will have access to continuous glucose monitoring and ...

Read more →

New COVID-19 oral treatment on PBS

11 April 2022 - Greg Hunt's swan song press release. ...

Read more →

Faster patient access to new medicines must be a priority for next Government

10 April 2022 - With the Federal Election campaign now formally underway, Medicines Australia is reminding the major parties of ...

Read more →

PBS listing of Paxlovid (nirmatrelvir and ritonavir)

 9 April 2022 - Commencing 1 May 2022, Paxlovid (nirmatrelvir and ritonavir) will be listed on the PBS as a General ...

Read more →

Price slashed for revolutionary $78,000 a year prostate cancer treatment Lynparza

1 April 2022 - A new subsidy for a revolutionary drug is set to benefit thousands of Aussie men with aggressive ...

Read more →

Making medicines more affordable for more Australians

1 April 2022 - Australians will have cheaper access to treatments for high cholesterol, heart failure and high blood pressure from ...

Read more →

Schedule of Pharmaceutical Benefits - 1 April 2022

1 April 2022 - The April 2022 issue of the Schedule of Pharmaceutical Benefits is out and now in effect. ...

Read more →

Federal budget 2022: more funding for breast cancer drug Trodelvy

29 March 2022 - Against all the odds Sydney mum Alison Day will get to celebrate her daughter’s 12th birthday — ...

Read more →